PT2144934T - Anticorpos contra il-25 - Google Patents

Anticorpos contra il-25

Info

Publication number
PT2144934T
PT2144934T PT87370250T PT08737025T PT2144934T PT 2144934 T PT2144934 T PT 2144934T PT 87370250 T PT87370250 T PT 87370250T PT 08737025 T PT08737025 T PT 08737025T PT 2144934 T PT2144934 T PT 2144934T
Authority
PT
Portugal
Prior art keywords
antibodies against
antibodies
Prior art date
Application number
PT87370250T
Other languages
English (en)
Inventor
Neil James Mckenzie Andrew
Ballantyne Sarah
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of PT2144934T publication Critical patent/PT2144934T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT87370250T 2007-04-18 2008-04-17 Anticorpos contra il-25 PT2144934T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91247407P 2007-04-18 2007-04-18
GBGB0707505.4A GB0707505D0 (en) 2007-04-18 2007-04-18 Antibodies against il-25

Publications (1)

Publication Number Publication Date
PT2144934T true PT2144934T (pt) 2016-12-02

Family

ID=38135020

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87370250T PT2144934T (pt) 2007-04-18 2008-04-17 Anticorpos contra il-25

Country Status (32)

Country Link
US (1) US8206717B2 (pt)
EP (1) EP2144934B1 (pt)
JP (1) JP5366930B2 (pt)
KR (1) KR101605861B1 (pt)
CN (1) CN101711256B (pt)
AU (1) AU2008240436B2 (pt)
BR (1) BRPI0810418A8 (pt)
CA (1) CA2684492C (pt)
CO (1) CO6260104A2 (pt)
CR (1) CR11079A (pt)
CY (1) CY1118244T1 (pt)
DK (1) DK2144934T3 (pt)
EA (1) EA018073B1 (pt)
EC (1) ECSP099726A (pt)
ES (1) ES2604255T3 (pt)
GB (1) GB0707505D0 (pt)
GT (1) GT200900271A (pt)
HN (1) HN2009003038A (pt)
HR (1) HRP20161548T1 (pt)
HU (1) HUE030935T2 (pt)
IL (1) IL201552A (pt)
LT (1) LT2144934T (pt)
MX (1) MX2009011234A (pt)
MY (1) MY148451A (pt)
NI (1) NI200900189A (pt)
NZ (1) NZ581178A (pt)
PL (1) PL2144934T3 (pt)
PT (1) PT2144934T (pt)
RS (1) RS55401B1 (pt)
SI (1) SI2144934T1 (pt)
UA (1) UA100377C2 (pt)
WO (1) WO2008129263A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0817891D0 (en) * 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25
US8574582B2 (en) * 2008-10-31 2013-11-05 Janssen Biotech, Inc. Methods for mediating fibrotic response
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
WO2011032119A1 (en) 2009-09-14 2011-03-17 The Regents Of The University Of Colorado Modulation of yeast-based immunotherapy products and responses
DK2552961T3 (en) 2010-03-30 2018-03-05 Janssen Biotech Inc HUMANIZED IL-25 ANTIBODIES
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN103792375B (zh) * 2014-01-29 2017-07-07 华中科技大学同济医学院附属同济医院 外周血白细胞介素25水平在哮喘分型中的应用及分型方法
EA036658B1 (ru) 2014-09-23 2020-12-04 Регенерон Фармасьютикалз, Инк. Антитела к il-25 и их применения
KR102477922B1 (ko) * 2016-03-16 2022-12-14 아베오미 코포레이션 Il-25에 대한 중화 모노클로날 항체 및 그의 용도
WO2018017864A2 (en) * 2016-07-20 2018-01-25 Oncomed Pharmaceuticals, Inc. Pvrig-binding agents and uses thereof
WO2018018082A1 (en) 2016-07-26 2018-02-01 The Australian National University Immunostimulatory compositions and uses therefor
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
AU2018450414A1 (en) * 2018-11-19 2021-05-20 Beijing Kanova Biopharmaceutical Co., Ltd. Anti-IL-25 antibodies and use thereof
GB202018015D0 (en) 2020-11-16 2020-12-30 Res & Innovation Uk Composition and methods for the treatment of intestinal cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
CN1289668C (zh) * 2003-06-12 2006-12-13 北京安波特基因工程技术有限公司 一种用于抗体改形的体外分子定向进化方法
EP1863520B1 (en) 2005-03-08 2014-12-31 Aptose Biosciences Inc. Use of interleukin 17e for the treatment of cancer
CA2658833A1 (en) 2005-10-06 2007-04-19 Baylor Research Institute Compositions and methods for the treatment of cancer
GB0817891D0 (en) 2008-09-30 2008-11-05 Medical Res Council Antibodies against il-25

Also Published As

Publication number Publication date
CA2684492C (en) 2015-11-24
CO6260104A2 (es) 2011-03-22
US20100129380A1 (en) 2010-05-27
JP2010524450A (ja) 2010-07-22
EP2144934B1 (en) 2016-08-24
GT200900271A (es) 2010-11-03
HUE030935T2 (en) 2017-06-28
KR20100021569A (ko) 2010-02-25
EP2144934A1 (en) 2010-01-20
DK2144934T3 (en) 2016-12-12
KR101605861B1 (ko) 2016-03-24
EA018073B1 (ru) 2013-05-30
CR11079A (es) 2010-03-03
UA100377C2 (en) 2012-12-25
NZ581178A (en) 2012-01-12
PL2144934T3 (pl) 2017-07-31
BRPI0810418A2 (pt) 2014-10-14
CN101711256B (zh) 2013-10-16
NI200900189A (es) 2010-09-13
BRPI0810418A8 (pt) 2018-12-11
HRP20161548T1 (hr) 2016-12-30
AU2008240436B2 (en) 2011-03-17
AU2008240436A1 (en) 2008-10-30
IL201552A0 (en) 2010-05-31
LT2144934T (lt) 2016-12-27
WO2008129263A1 (en) 2008-10-30
ECSP099726A (es) 2010-01-29
EA200901421A1 (ru) 2010-10-29
CY1118244T1 (el) 2017-06-28
JP5366930B2 (ja) 2013-12-11
CN101711256A (zh) 2010-05-19
GB0707505D0 (en) 2007-05-30
SI2144934T1 (sl) 2016-12-30
ES2604255T3 (es) 2017-03-06
CA2684492A1 (en) 2008-10-30
MY148451A (en) 2013-04-30
US8206717B2 (en) 2012-06-26
IL201552A (en) 2015-08-31
RS55401B1 (sr) 2017-04-28
HN2009003038A (es) 2011-11-11
MX2009011234A (es) 2010-02-18

Similar Documents

Publication Publication Date Title
IL201552A0 (en) Antibodies against il-25
GB0708002D0 (en) Antibodies
HRP20150224T1 (en) Anti mif antibodies
HK1185622A1 (en) Axl antibodies axl
HK1136970A1 (en) Penta-specific antibody
EP2241578A4 (en) ANTI-CLDN6 ANTIBODIES
EP2138576A4 (en) ANTI-CLAUDIN-4 ANTIBODY
GB0821100D0 (en) Antibodies
SI2200700T1 (sl) Nova protitelesa
EP2172483A4 (en) ANTI-MUC17 ANTIBODY
EP2337798A4 (en) BSA-SPECIFIC ANTIBODIES
HK1154022A1 (en) Antibodies against il-25 il-25
GB0718737D0 (en) Antibodies
IL205073A0 (en) Anti-bst2 antibody
GB0702888D0 (en) Novel Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
GB0911770D0 (en) Antibody
GB0724185D0 (en) Antibodies
GB0823562D0 (en) Antibodies
GB0806230D0 (en) Antibodies
GB0817622D0 (en) Antibody
GB0817621D0 (en) Antibody